Rosetta Genomics Licenses microRNA Genes from Rockefeller University | GenomeWeb
NEW YORK (GenomeWeb News) – Rosetta Genomics said today that it has licensed non-exclusive rights to microRNA genes for research applications from Rockefeller University.
 
The agreement covers viral and human microRNAs that Rosetta intends to add to its existing intellectual property portfolio, which currently includes two issued patents, two allowed patent applications, and 60 pending patent applications. The Rehovot, Israel-based firm previously licensed from Rockefeller rights to microRNAs for therapeutic and diagnostic uses.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.